Bank of New York Mellon Corp - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 45 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 2.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$392,000
-27.8%
122,693
-3.5%
0.00%
Q1 2022$543,000
-3.7%
127,084
+4.8%
0.00%
Q4 2021$564,000
+102.9%
121,303
+74.6%
0.00%
Q3 2021$278,000
-9.2%
69,494
-2.5%
0.00%
Q2 2021$306,000
-39.9%
71,283
-40.8%
0.00%
Q1 2021$509,000
+100.4%
120,348
+84.0%
0.00%
Q4 2020$254,000
-7.3%
65,423
-3.8%
0.00%
Q3 2020$274,000
-11.3%
68,021
-6.5%
0.00%
Q2 2020$309,000
+1.6%
72,727
+0.3%
0.00%
Q1 2020$304,000
+8.2%
72,545
+1.6%
0.00%
Q4 2019$281,000
-60.7%
71,409
-12.0%
0.00%
Q3 2019$715,000
-0.8%
81,161
+4.1%
0.00%
Q2 2019$721,000
+22.8%
77,992
-14.6%
0.00%
Q1 2019$587,000
-26.9%
91,285
+7.2%
0.00%
Q4 2018$803,000
-56.1%
85,150
-6.4%
0.00%
Q3 2018$1,831,000
-31.9%
90,949
-1.4%
0.00%
-100.0%
Q2 2018$2,689,000
+4.7%
92,226
+6.9%
0.00%0.0%
Q1 2018$2,569,000
-4.7%
86,262
+3.0%
0.00%0.0%
Q4 2017$2,695,000
-7.5%
83,754
+0.0%
0.00%0.0%
Q3 2017$2,912,000
+18.1%
83,744
+1.1%
0.00%0.0%
Q2 2017$2,466,000
+8.4%
82,847
+8.8%
0.00%0.0%
Q1 2017$2,274,000
+81.2%
76,180
+6.5%
0.00%
Q4 2016$1,255,000
-22.8%
71,561
+4.7%
0.00%
Q3 2016$1,625,000
+50.9%
68,328
+1.4%
0.00%
Q2 2016$1,077,000
-28.6%
67,369
-6.6%
0.00%
Q1 2016$1,509,000
-2.6%
72,136
+25.6%
0.00%
Q4 2015$1,550,000
-13.1%
57,412
-10.5%
0.00%
-100.0%
Q3 2015$1,783,000
+63.3%
64,156
+44.0%
0.00%
Q2 2015$1,092,00044,5410.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q4 2021
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders